FTC: Legal settlements delay cheaper drugs
                   
signonsandiego.com     22-May-2008            

WASHINGTON – Pharmaceutical companies are using legal settlements with generic drugmakers to delay the introduction of cheaper medicines, a government agency said Wednesday. “Pay-for-delay settlements continue to proliferate,” FTC Commissioner Jon Leibowitz said in a statement. The Pharmaceutical... [read full story]                    


View all news articles about*:
Cephalon Corporate Crime Crimes Drug Drugs Generic Industrial Intellectual Issues Lawsuits Legal Medicines Patents Pharmaceuticals Property Remedies
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

John Dawson does have form in the City

iii.co.uk     8 hrs ago          

After leaving Cephalon in 2007, John Dawson was appointed as a non-exec to Ardana plc. Here's the press release from December 2007: "In order to augment Ardana’s business development capability the Company has appointed...                    

comments

Tired All The Time? It May Be Sleep Apnea

medicalnewstoday.com     21-Aug-2008   2 related          

Repetitive blockages of the airway, called obstructive sleep apnea (OSA), can reduce airflow or cause breathing to stop. When this happens, frequent brief awakenings can leave a person feeling excessively sleepy during the day,...                    

comments

Research and Markets: Essential Chartbook of International Pharmaceutical Prices for 2008 from...

pharmiweb.co.uk     20-Aug-2008   1 related          

More News related to Press Releases ) has announced the addition of Decision Resources, Inc.'s new report "2008 Chartbook of International Pharmaceutical Prices" to their offering. To best determine pricing, pharmaceutical...                    

comments

                   

Bioxel Pharma: 2008 Second Quarter Results

pharmiweb.co.uk     1 hr ago   2 related          

Bioxel Pharma Inc. (TSX VENTURE: BIP), a leading manufacturer of taxane active pharmaceutical ingredients (APIs) and developer of targeted oncology drugs, today announced its results for the second quarter ended June 30,...                    

comments